Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Risk for Premature Mortality Increased With History of Endometriosis
THURSDAY, Nov. 21, 2024 -- Women with a history of endometriosis and uterine fibroids may have an increased risk for premature mortality, according to a study...
Fine Particulate Matter Linked to Increased Incidence of Head, Neck Cancer
THURSDAY, Nov. 21, 2024 -- Exposure to air pollution in the form of particulate matter measuring less than 2.5 µm (PM2.5) is associated with an increased...
U.S. Overweight, Obesity Rates Set to Continue Increasing to 2050
THURSDAY, Nov. 21, 2024 -- Based on the current trajectory, overweight and obesity will continue increasing in the United States up to 2050, according to a...
24.3 Percent of U.S. Adults Had Chronic Pain in Past Three Months in 2023
THURSDAY, Nov. 21, 2024 -- In 2023, 24.3 percent of U.S. adults had chronic pain in the previous three months, according to a November data brief published by...
E. Coli Fears Spur Recall of 167,000 Pounds of Ground Beef
THURSDAY, Nov. 21, 2024 -- Over 167,000 pounds of ground beef are being recalled by a Detroit meatpacker after being linked to E. coli illnesses in restaurant...
Optimal Timing of Maternal RSV Vaccine Determined to Be at Least Five Weeks Before Delivery
THURSDAY, Nov. 21, 2024 -- Respiratory syncytial virus (RSV) vaccination at least five weeks prior to delivery results in the highest transplacental transfer...
Chronic Joint Pain Plus Depression Can Take Toll on the Brain
THURSDAY, Nov. 21, 2024 -- Having achy, painful joints isn't just a physical woe: Coupled with depression, it could also degrade an older person's brain...
1 in 4 Americans Now Struggling to Cover Medical Costs
THURSDAY, Nov. 21, 2024 -- U.S. health care costs are among the world's highest, and 1 in 4 adults with health coverage struggle with high out-of-pocket costs...
Weight-Loss Drug Zepbound May Lower Heart Failure Deaths
THURSDAY, Nov. 21, 2024 -- A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial...
Getting Fitter Can Really Help Keep Dementia at Bay
THURSDAY, Nov. 21, 2024 -- People whose genes put them at high risk for dementia may be able to fight Mother Nature and win, new research out of Sweden...
FDA Grants Accelerated Approval to Ziihera (zanidatamab-hrii) for the Treatment of HER2-Positive Biliary Tract Cancer
DUBLIN, Nov. 20, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) accelerated approval...
UCB Receives U.S. FDA Approval for Bimzelx (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate to Severe Hidradenitis Suppurativa
Brussels (Belgium), November 20, 2024 – 07:00 (CET) – UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug...
Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
PASADENA, Calif.–(BUSINESS WIRE)–Nov. 18, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it submitted a New Drug...
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease
LEXINGTON, Mass.--(BUSINESS WIRE)--Nov. 18, 2024-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug...
FDA Approves Revuforj (revumenib) for the Treatment of Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
WALTHAM, Mass., Nov. 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Danziten (nilotinib) Tablets, the First and Only Nilotinib With No Mealtime Restrictions
WOBURN, Mass. Nov 14, 2024 – Azurity Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Danziten, the first...
FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency
WARREN, N.J., Nov. 13, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) accelerated...
Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
CLEVELAND, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the U.S. Food and Drug Administration (FDA) has...
Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
12 November 2024 -- AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab...
Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
LOS ALTOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies...
First Patient Dosed in Clinical Trial of ABI-110, a Groundbreaking Gene Therapy for Wet AMD Including PCV
HAYWARD, Calif., Nov. 21, 202. Avirmax Biopharma, Inc., a leader in the development of innovative gene therapies, today announced that the first patient has...
Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
BRUSSELS, Belgium and CAMBRIDGE, Mass. – November 19, 2024 – UCB (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ: BIIB) today presented detailed...
Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
RAHWAY, N.J. November 19, 2024 -- Merck, known as MSD outside of the United States and Canada, today announced positive topline results from the pivotal Phase...
Cardiovascular Researchers Dramatically Reduce Size and Severity of Stroke Using Antidiabetic Drug in Preclinical Models
PASADENA, Calif., Nov. 19, 2024. Huntington Medical Research Institutes (HMRI), a pioneer in scientific research with a track record of groundbreaking...
Linerixibat Shows Positive Phase III Results in Cholestatic Pruritus in Primary Biliary Cholangitis (PBC)
19 November 2024 -- GSK plc (LSE/NYSE: GSK) today announced positive headline results of GLISTEN, the ongoing global phase III clinical trial evaluating...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.